P414: RNA MODIFICATION‐FOCUSED CRISPR‐CAS9 SCREEN REVEALS POTENTIAL THERAPEUTIC TARGETS MEDIATING CHEMORESISTANCE IN AML
Kienhöfer, M., Pauli, C., Delaunay, S., Rohde, C., Blank, M. F., Heid, D., Frye, M., Müller‐Tidow, C.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
PB1976: CRISPR‐CAS9 KNOCKOUT SCREEN IDENTIFIES RNA MODIFICATION ENZYMES ESSENTIAL FOR CELL SURVIVAL IN MULTIPLE MYELOMA
Zhao, D., Pauli, C., Rohde, C., Kienhöfer, M., Grab, A. L., Huhn, S., Raab, M., Weinhold, N., Frye, M., Müller‐Tidow, C.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article